Dianthus Therapeutics (DNTH) Earnings Date & Reports

Get AI intraday signals

A.I. Advisor

published Earnings

DNTH is expected to report earnings to fall 19.58% to -303 cents per share on September 18

Dianthus Therapeutics DNTH Stock Earnings Reports

Q2'23

Est.

$-3.04

Q3'23

Missed

by $3.22

Q1'23

Missed

by $0.07

Q4'22

Missed

by $0.02

Q3'22

Beat

by $0.02

The last earnings report on November 09 showed earnings per share of -377 cents, missing the estimate of -56 cents. With 90.11K shares outstanding, the current market capitalization sits at 718.32M.

View a ticker or compare two or three

Compare

DNTH

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For DNTH
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for DNTH (Try 14 days for Free)

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

7 Times Square

Phone

+1 929 999-4055

Employees

Web

https://www.dianthustx.com